Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00934505 |
Date of registration:
|
07/07/2009 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinoma
RTEP3 |
Scientific title:
|
Predictive Value of FDG-TEP During Exclusive Chemo-Radiotherapy (CRT) in Patients With Oesophageal Carcinoma Cancer on the One-Year Survival (RTEP3) |
Date of first enrolment:
|
May 2009 |
Target sample size:
|
100 |
Recruitment status: |
Recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT00934505 |
Study type:
|
Observational |
Study design:
|
Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
VERA Pierre, MD phD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
CHBecquerel |
|
Name:
|
MICHEL Pierre, MD phD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
CHRU Rouen |
|
Name:
|
THILLAYS Marc, RT |
Address:
|
|
Telephone:
|
0033232082497 |
Email:
|
marc.thillays@touen.fnclcc.fr |
Affiliation:
|
|
|
Name:
|
THILLAYS Marc, RCA |
Address:
|
|
Telephone:
|
00330232082497 |
Email:
|
marc.thillays@rouen.fnclcc.fr |
Affiliation:
|
|
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Carcinoma épidermoïde of the oesophagus histologically proved, UICC Stage II B, III
or IVa (TNM on 2002)
- Decision of treatment by radio concomitant chemotherapy (radiotherapy in classic
spreading of 50Gy associated with a platinum chemotherapy.
Exclusion Criteria:
- Presence of a second evolutionary cancer in the previous three years
- index of performance OMS > 2
- Patients badly balanced diabetics
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Oesophageal Cancer
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|